Oncology Market Opportunities, Strategies, and Forecasts, 2006 to Oncology. Picture by Susie Eustis MOUNTAINS OF OPPORTUNITY
|
|
- Berenice Richard
- 5 years ago
- Views:
Transcription
1 Oncology Market Opportunities, Strategies, and Forecasts, 2006 to 2012 Oncology Picture by Susie Eustis MOUNTAINS OF OPPORTUNITY WinterGreen Research, Inc. Lexington, Massachusetts
2 CHECK OUT THESE KEY TOPICS ONCOLOGY MARKET SHARES ONCOLOGY MARKET FORECASTS Oncology Market Driving Forces Nanotechnology Cancer Treatment Market Forecasts Lung Cancer Breast Cancer COLORECTAL CANCER OVARIAN CANCER PROSTATE CANCER ANGIOGENESIS GOLD NANOPARTICLES AND LASERS CANCER SURGERY SPECTRX TUNABLE LASER MARKET ANALYSIS EKIPS ASTHMA TESTING EKIPS TECHNOLOGIES GIVEN DIAGNOSTIC SYSTEM OPPORTUNITY ABOUNDS OPPORTUNITY ABOUNDS WinterGreen Research, Inc. Lexington, Massachusetts
3 Oncology Market Opportunities, Market Forecasts, and Market Strategies, Between 2000 and 2020, the World Health Organization is predicting a 50% rise in the global incidence of cancer. Fortunately for those diagnosed with cancer between now and 2020, cancer treatments are also projected to evolve along with the cancer market, creating options for the afflicted. However, these options come at a significant price. Prescription drug costs have spiraled from $12 billion annually in 1980 to $179 billion in 2003, according to the Center for Medicare and Medicaid Services. In addition, cancer drugs will be the fastest-growing part of the drug market for the next five years, with costs rising 20 percent a year, according to many analysts. Every major drug maker is now investing heavily in oncology, rushing to capitalize on new research about the way cancer cells reproduce. With the cancer market struggling with few new drugs only 1 of 20 cancer drugs developed reach the market and expensive drugs, the FDA hopes to develop new tests to assess a patient s cancer. Instead of the old test that simply uses X-rays, the FDA wants to employ imaging, blood tests, as well as other techniques to better assess a patient s progression of cancer. X-rays only measure the size of the tumor, and a smaller tumor after use of a drug does not necessarily mean the tumor is any less dangerous. With these new tests to measure success against cancer, cancer drugs would be able to make it to market quicker. Using chemotherapy as an example, patients with advanced disease used to live an average of one year, at a cost of $63 for an initial 8-week treatment. A newer drug regimen has extended survival to 21 months, but at a cost of $12,000. Situations like this stress the ailing U.S. health care system, raising questions about the cost of endof-life care. The oncology market will grow steadily due to numerous factors, including the aging population, new treatments available, the unraveling of the genetics behind cancer, and the fact that cancer is a significant disease with many variations. The oncology market forecasts show an increase from 18 million in 2004 to over 195 Million in 2012.
4 Companies Profiled Market Leaders Amgen AstraZeneca Genentech Market Participants Bristol-Myers Squibb OSI Pharmaceuticals Sanofi-Aventis Novartis Merck GlaxoSmithKline Millennium ImClone Systems Abgenix Eli Lilly Onyx / Bayer Pfizer
5 Oncology Strategies and Forecasts, REPORT METHODOLOGY THIS IS THE 271ST REPORT IN A SERIES OF MARKET RESEARCH REPORTS THAT PROVIDE FORECASTS IN COMMUNICATIONS, TELECOMMUNICATIONS, THE INTERNET, COMPUTER, SOFTWARE, TELEPHONE EQUIPMENT, HEALTH EQUIPMENT, AND ENERGY. THE PROJECT LEADERS TAKE DIRECT RESPONSIBILITY FOR WRITING AND PREPARING EACH REPORT. THEY HAVE SIGNIFICANT EXPERIENCE PREPARING INDUSTRY STUDIES. FORECASTS ARE BASED ON PRIMARY RESEARCH AND PROPRIETARY DATA BASES. FORECASTS REFLECT ANALYSIS OF THE MARKET TRENDS IN THE SEGMENT AND RELATED SEGMENTS. UNIT AND DOLLAR SHIPMENTS ARE ANALYZED THROUGH CONSIDERATION OF DOLLAR VOLUME OF EACH MARKET PARTICIPATION IN THE SEGMENT. INSTALLED BASE ANALYSIS AND UNIT ANALYSIS IS BASED ON INTERVIEWS AND AN INFORMATION SEARCH. MARKET SHARE ANALYSIS INCLUDES CONVERSATIONS WITH KEY CUSTOMERS OF PRODUCTS, INDUSTRY SEGMENT LEADERS, MARKETING DIRECTORS, DISTRIBUTORS, LEADING MARKET PARTICIPANTS, OPINION LEADERS, AND COMPANIES SEEKING TO DEVELOP MEASURABLE MARKET SHARE. OVER 200 IN DEPTH INTERVIEWS ARE CONDUCTED FOR EACH REPORT WITH A BROAD RANGE OF KEY PARTICIPANTS AND INDUSTRY LEADERS IN THE MARKET SEGMENT. WE ESTABLISH ACCURATE MARKET FORECASTS BASED ON ECONOMIC AND MARKET CONDITIONS AS A BASE. USE INPUT/OUTPUT RATIOS, FLOW CHARTS, AND OTHER ECONOMIC METHODS TO QUANTIFY DATA. USE IN-HOUSE ANALYSTS WHO MEET STRINGENT QUALITY STANDARDS. INTERVIEWING KEY INDUSTRY PARTICIPANTS, EXPERTS AND END-USERS. OUR RESEARCH INCLUDES ACCESS TO LARGE PROPRIETARY DATABASES. LITERATURE SEARCH INCLUDES ANALYSIS OF TRADE PUBLICATIONS, GOVERNMENT REPORTS, AND CORPORATE LITERATURE. YOU MUST HAVE THIS STUDY
6 Oncology Market Opportunities, Strategies, and Forecasts, 2006 to 2012 Table of Contents ONCOLOGY EXECUTIVE SUMMARY ONCOLOGY EXECUTIVE SUMMARY Oncology Market Driving Forces Oncology Market Shares Oncology Market Forecasts Nanotechnology Cancer Treatment Market Forecasts ES-1 ES-1 ES-2 ES-3 ES-4 ONCOLOGY MARKET DESCRIPTION AND MARKET DYNAMICS 1. ONCOLOGY MARKET DESCRIPTION AND MARKET DYNAMICS Oncology Market Lung Cancer Non-Small Cell Lung Cancer Breast Cancer Colorectal Cancer Ovarian Cancer Ovarian Cancer Types Prostate Cancer Angiogenesis Gold Nanoparticles and Lasers Cancer Surgery Argon Ion Laser At 514nm Cancer Detection and Diagnosis Using Minimally/Non-Invasive Optical Techniques Bacteria and Virus Detection for Homeland Defense Compact Photonic Explorer Tunable Laser Market Analysis Tunable Laser Medical Systems Tunable Laser Demand Mid IR Medical Tunable Laser Market Medical Mid Range IR Tunable Laser Forecasts, Units and Dollars Breath Meter Asthma Screening And Asthma Therapeutic Monitoring Use Of Tunable Lasers For Cancer Diagnosis And Treatment Using Light To Effect Definitive Diagnosis Of Breast Cancer Gold Nanoparticles and Lasers in the Otolaryngology-Head and Neck Surgery Noninvasive Medical Diagnostics Depend on Using Human Tissue Transparent Wavelength Mediscience Technology Tunable Laser Medical Systems Ekips Asthma Testing Ekips Breathmeter Mediscience Technology SpectRx SpectRx Cancer Detection Business 1-27
7 1.17 Gold Nanoparticles and Lasers in the Otolaryngology-Head and Neck Surgery Ekips Technologies Users Blow Into A Breathmeter To Diagnose First Stages Of Cancer, Diabetes, Or Some Other Chronic Disease Given Diagnostic System Given System Clinical Results Mediscience Technology Mediscience Technology Ability To Continue Operations 1-35 ONCOLOGY MARKET SHARES AND MARKET FORECASTS 2. ONCOLOGY MARKET SHARES AND MARKET FORECASTS Market Overview Patents Medicare Oncology Market Shares Amgen AstraZeneca Genentech Bristol-Myers Squibb Millennium Chemotherapy Breast Cancer Prostate Cancer Ovarian Cancer Colorectal Cancer Non-Small Lung Cancer Amgen 2005 Sales AstraZeneca 2005 Sales Genentech 2005 Sales Bristol-Myers Squibb 2005 Sales Millennium 2005 Sales Competition Biotechnology Competition Cancer Competition Oncology Market Driving Forces Oncology Market Forecasts Nanotechnology Cancer Treatment 2-78 ONCOLOGY PRODUCT DESCRIPTION 3. ONCOLOGY PRODUCT DESCRIPTION Amgen Chemotherapy Aranesp (Chemotherapy) Neupogen (Chemotherapy) Neulasta (Chemotherapy) Kepivance (Chemotherapy) Panitumumab (Colorectal Cancer) AMG 162 and AMG 706 (Bone Loss Resulting From Cancer) AstraZeneca Arimidex (Breast Cancer) Casodex (Prostate Cancer) 3-5
8 3.2.3 Faslodex (Breast Cancer) Iressa (Non-Small Lung Cancer) Nolvadex (Breast Cancer) Tomudex (Colorectal Cancer) Zoladex (Prostate / Breast Cancer) Genentech VEGF and Tumor Angiogenesis Genentech Avastin Genentech Avastin (Colorectal Cancer) Genentech Avastin (Non-Small Lung) Genentech Avastin (Breast Cancer) Genentech Avastin Safety Genentech Herceptin (Breast Cancer) Genentech Herceptin Proposed Mechanism of Action (Breast Cancer) Genentech Herceptin Safety Genentech Rituxan (Non-Hodgkin) Genentech Tarceva (Non-Small Lung) OSI Tarceva (Non-Small Lung) Tarceva (Pancreatic Cancer) Tarceva Safety Genentech Omnitarg (Ovarian Cancer) (OSI) Novantrone (Angiogenesis) Genentech Apo2L/TRAIL Roche Group Roche Cancer Diagnostic Tests (General) Bristol-Myers Squibb Erbitux [Cetuximab] Erbitux (Colorectal Cancer) Erbitux (Ovarian Cancer) Erbitux (Head / Neck Cancer) Millennium Velcade (Myeloma) Velcade (Non-Small Lung Cancer) Aventis Taxotere Taxotere (Breast Cancer) Taxotere (Non-Small Cell Lung Cancer ((NSCLC)) Taxotere (Prostate Cancer) Anzemet (Chemotherapy) Bayer / Onyx Sorafenib (Melanoma) Eli Lilly Alimta (Non-Small Lung) Gemzar (Non-Small Lung Cancer) Gemzar (Pancreatic Cancer) Gemzar (Breast Cancer) Enzastaurin (Brain Cancer) GlaxoSmithKline Zofran (Chemotherapy) Alkeran (Ovarian Cancer) Hycamtin (Non-Small Lung) Merck 3-35
9 Emend (Chemotherapy) Novartis Femara (Breast Cancer) Aredia (Colorectal Cancer) Gleevec (Prostate Cancer) ZOMETA (Prostate/ Bone Cancer) PTK/ZK (Colorectal Cancer) Gleevec/Glivec (Breast Cancer) Pfizer Aromasin (Breast Cancer) Camptosar (Colorectal Cancer) Ellence (Breast Cancer) Sutent/SU11248 (Colorectal Cancer) 3-41 ONCOLOGY TECHNOLOGY 4. ONCOLOGY TECHNOLOGY Amgen AstraZeneca AstraZeneca Oncology Research Genentech HER Family Tumor Antigen Project Angiogenesis Apoptosis STOP Cancer Project Bristol-Myers Squibb Millennium Cancer Genes 4-12 ONCOLOGY COMPANY PROFILES 5. ONCOLOGY COMPANY PROFILES Amgen Reimbursement Patents and Trademarks AstraZeneca Genentech Genentech BioOncology Genentech s Robust Pipeline Bristol-Myers Squibb Millennium OSI Pharmaceuticals ImClone Systems Sanofi-Aventis Abgenix Novartis Aventis Eli Lilly Merck Onyx / Bayer GlaxoSmithKline Pfizer 5-23
10 List of Tables and Figures ONCOLOGY EXECUTIVE SUMMARY Table ES-1 Oncology Market Driving Forces Figure ES-2 Oncology Market Shares, Segment Percents, 2004 Figure ES-3 Oncology Market Forecasts, Dollars, Figure ES-4 Nanotechnology Cancer Treatment Market Forecasts, Dollars, ES-1 ES-3 ES-4 ES-5 ONCOLOGY MARKET DESCRIPTION AND MARKET DYNAMICS Table Ovarian Cancer Stages Table Gold Nanoparticles And Lasers In Selective Photothermal Agents Target Cancer Elimination At The Molecular Level Table Reasons Tunable Lasers Replace Spirometry Table Worldwide Medical Mid IR Tunable Laser Market Forecasts, Shipments, Dollars, ONCOLOGY MARKET SHARES AND MARKET FORECASTS Figure Oncology Market Shares, Segment Percents, 2004 Table Oncology Market Product Sales Figure Industry Total Revenue Segment Percents, 2004 Table Industry Total Revenue Figure Amgen Total Revenue, Dollars Figure Amgen Total Product Sales, Dollars Table Amgen s Total Revenue and Product Sales From Figure Amgen s Total Product Sales, Dollars, 2004 Table Amgen s Product Sales Figure Amgen s Total Product Sales Continued, Dollars, 2004 Table Amgen s Product Sales, Continued Figure Amgen s Product Sales, Dollars, 2003
11 Figure Amgen s Product Sales Figure Amgen s Total Product Sales Continued, Dollars, 2003 Figure Amgen s Total International Product Sales, Dollars Figure Amgen s Total U.S. Product Sales, Dollars Table Amgen s Regional Product Sales Figure AstraZeneca Net Sales, Dollars, 2004 Figure AstraZeneca Net Sales, Dollars, 2003 Table AstraZeneca Product Sales Full Year Figure AstraZeneca Net Sales, Dollars, 1 st Quarter, 2005 Table AstraZeneca Product Sales, 1 st Quarter Figure AstraZeneca Geographic Product Sales, Segments Percents, 2004 Figure AstraZeneca Geographic Product Sales, Segments Percents, 2003 Table AstraZeneca Geographic Sales Full Year Figure Genentech s Total Revenue, Dollars Figure Genentech Total Product Sales, Dollars Table Genentech Figure Genentech Total Product Sales, Dollars, 2004 Table Genentech Oncology Product Sales Figure Genentech Net Foreign Revenues, Segment Percents, 2004 Figure Genentech Net Foreign Revenues, Segment Percents, 2004 Table Genentech Net Foreign Revenues Figure Bristol-Myers Squibb s Worldwide Net Sales, Dollars, 2004 Table Bristol-Myers Squibb s Product Sales Figure Bristol-Myers Squibb s U.S. Net Sales, Dollars, 2004 Table Bristol-Myers Squibb s U.S. Net Sales Figure Millennium s Total Revenues, Dollars
12 Table Millennium s Product Sales and Revenues Table Millennium s Product Sales Figure Chemotherapy Product Sales, Segment Percents, 2004 Table Chemotherapy Product Sales Figure Chemotherapy Total Product Sales, Dollars, 2004 Figure Chemotherapy Total Product Sales Continued, Dollars, 2004 Table Chemotherapy Product Sales Continued Figure Aranesp Total Product Sales, Dollars, 2004 Table Chemotherapy Product Sales Figure Breast Cancer Product Sales, Segment Percents, 2004 Table Breast Cancer Product Sales Figure Breast Cancer Total Product Sales, Dollars, 2004 Figure Breast Cancer Total Product Sales, Dollars, 2003 Table Breast Cancer Product Sales Full Year Figure Breast Cancer Total Product Sales, Dollars, 1 st Quarter, 2005 Table Breast Cancer Product Sales 1 st Quarter Figure Breast Cancer Total Product Sales For Herceptin (Genentech), Dollars Table Breast Cancer Product Sales Figure Prostate Cancer Product Sales, Dollars, 2004 Figure Prostate Cancer Product Sales, Dollars, 2003 Table Prostate Product Sales Figure Prostate Cancer U.S. Net Sales, Dollars, 2004 Figure Prostate Cancer U.S. Net Sales, Dollars, 2003 Table Prostate Cancer U.S. Net Sales Full Year Figure Prostate Cancer U.S. Net Sales, Dollars, 1 st Quarter, 2005 Table Prostate U.S. Net Sales 1 st Quarter
13 Figure Ovarian Cancer Product Sales, Dollars, 2004 Table Ovarian Total Product Sales Figure Colorectal Cancer Product Sales, Dollars, 2004 Table Colorectal Product Sales Figure Colorectal Cancer Worldwide Net Sales For Erbitux (Bristol-Myers Squibb), Dollars Table Colorectal Worldwide Net Sales Figure Non-Small Lung Product Sales, Segment Percents, 2004 Table Non-Small Lung Product Sales Figure Non-Small Lung Cancer Total Product Sales, Dollars, 2004 Table Amgen, 3 rd Quarter 2005 Oncology Product Sales Table AstraZeneca 3 rd Quarter 2005 Oncology Product Sales Table Genentech 3 rd Quarter 2005 Oncology Product Sales Net U.S. Sales Table Bristol-Myers Squibb 3 rd Quarter 2005 Oncology Product Sales Table Millennium 3 rd Quarter 2005 Oncology Product Sales Table Oncology Market Driving Force Figure Oncology Market Forecasts, Dollars, Table Oncology Market Forecasts, Dollars, Figure Nanotechnology Cancer Treatment Market Forecasts, Dollars, Table Nanotechnology Cancer Treatment Market Forecasts, Dollars, ONCOLOGY PRODUCT DESCRIPTION Table Genentech late-stage clinical development program with Avastin Figure Genetech Herceptin Cell Action Table Effects Of Taking A Chemo Drug Like Ellence ONCOLOGY COMPANY PROFILES Table Amgen Material Patents
14 Table Genentech Robust Pipeline Table Novartis Product Areas
15 ABOUT THE COMPANY WINTERGREEN RESEARCH, HAS A UNIQUE RESEARCH STRATEGY THAT RELATES TO IDENTIFYING MARKET TRENDS THROUGH READING AND INTERVIEWING OPINION LEADERS. BY READING THE ELECTRONIC EQUIVALENT OF 40 FEET OF PAPER, WINTERGREEN RESEARCH SENIOR ANALYSTS CAN LEARN A LOT MORE ABOUT MARKETS, A LOT FASTER THAN CAN BE LEARNED THROUGH EXPENSIVE SURVEYS AND FOCUS GROUPS. THINKING ABOUT MARKET TRENDS IS A HIGH PRIORITY AT WINTERGREEN RESEARCH. AS WITH ALL RESEARCH, THE VALUE PROPOSITION FOR COMPETITIVE ANALYSIS COMES FROM INTELLECTUAL INPUT. IT IS A LUXURY REALLY, AVAILABLE TO ONLY A VERY FEW PEOPLE, TO BE ABLE TO GATHER INFORMATION, LOTS OF INFORMATION FROM READING MASSIVE AMOUNTS OF CONTENT, AND THEN TRYING TO MAKE SENSE OF THAT CONTENT. THE ABILITY TO THINK ABOUT MARKET TRENDS IS ENHANCED BY DOING IT OVER AND OVER FOR MANY DIFFERENT MARKETS. THAT IS WHAT WINTERGREEN RESEARCH IS ALL ABOUT: READING AND THINKING IS AN ESSENTIAL ASP ECT OF COMPETITIVE ANALYSIS. TALKING TO OPINION LEADERS IS THE THIRD ESSENTIAL ASPECT OF PRODUCING GOOD, RELIABLE DATA. WINTERGREEN RESEARCH, FOUNDED IN 1985, PROVIDES STRATEGIC MARKET ASSESSMENTS IN TELECOMMUNICATIONS, COMMUNICATIONS EQUIPMENT, HEALTH CARE, INTERNET AND ADVANCED COMPUTER TECHNOLOGY. INDUSTRY REPORTS FOCUS ON OPPORTUNITIES THAT EXPAND EXISTING MARKETS OR DEVELOP MAJOR NEW MARKETS. THE REPORTS ASSESS NEW PRODUCT AND SERVICE POSITIONING STRATEGIES, NEW AND EVOLVING TECHNOLOGIES, AND TECHNOLOGICAL IMPACT ON PRODUCTS, SERVICES, AND MARKETS. MARKET SHARES ARE PROVIDED. LEADING MARKET PARTICIPANTS ARE PROFILED, AND THEIR MARKETING STRATEGIES, ACQUISITIONS, AND STRATEGIC ALLIANCES ARE DISCUSSED. THE PRINCIPALS OF WINTERGREEN RESEARCH HAVE BEEN INVOLVED IN ANALYSIS AND FORECASTING OF INTERNATIONAL BUSINESS OPPORTUNITIES IN TELECOMMUNICATIONS AND ADVANCED COMPUTER TECHNOLOGY MARKETS FOR OVER 30 YEARS.
16 ABOUT THE PRINCIPAL AUTHORS ELLEN T. CURTISS, TECHNICAL DIRECTOR, CO-FOUNDER OF WINTERGREEN RESEARCH, CONDUCTS STRATEGIC AND MARKET ASSESSMENTS IN TECHNOLOGY-BASED INDUSTRIES. PREVIOUSLY SHE WAS A MEMBER OF THE STAFF OF ARTHUR D. LITTLE, INC., FOR 23 YEARS, MOST RECENTLY AS VICE PRESIDENT OF ARTHUR D. LITTLE DECISION RESOURCES, SPECIALIZING IN STRATEGIC PLANNING AND MARKET DEVELOPMENT SERVICES. SHE IS A GRADUATE OF BOSTON UNIVERSITY AND THE PROGRAM FOR MANAGEMENT DEVELOPMENT AT HARVARD GRADUATE SCHOOL OF BUSINESS ADMINISTRATION. SHE IS THE AUTHOR OF RECENT STUDIES ON WORLDWIDE TELECOMMUNICATIONS MARKETS, THE TOP TEN INTERNET EQUIPMENT COMPANIES, THE TOP TEN CONTRACT MANUFACTURING COMPANIES, AND THE TOP TEN TELECOMMUNICATIONS MARKET ANALYSIS AND FORECASTS. SUSAN EUSTIS, PRESIDENT, CO-FOUNDER OF WINTERGREEN RESEARCH, HAS DONE RESEARCH IN COMMUNICATIONS AND COMPUTER MARKETS AND APPLICATIONS. SHE HOLDS SEVERAL PATENTS IN MICROCOMPUTING AND PARALLEL PROCESSING. SHE HAS THE ORIGINAL PATENTS IN ELECTRONIC VOTING MACHINES. SHE HAS NEW PATENT APPLICATIONS IN FORMAT VARYING, MULITPROCESSING, AND ELECTRONIC VOTING. SHE IS THE AUTHOR OF RECENT STUDIES OF THE REGIONAL BELL OPERATING COMPANIES' MARKETING STRATEGIES, INTERNET EQUIPMENT, BIOMETRICS, A STUDY OF INTERNET EQUIPMENT, WORLDWIDE TELECOMMUNICATIONS EQUIPMENT, TOP TEN TELECOMMUNICATIONS, DIGITAL LOOP CARRIER, WEB HOSTING, WEB SERVICES, AND APPLICATION INTEGRATION MARKETS. MS. EUSTIS IS A GRADUATE OF BARNARD COLLEGE.
17 Return To: ORDER FORM WinterGreen Research, Inc. 6 Raymond Street Lexington, MA USA Phone: (781) Fax: (781) or (781) PLEASE ENTER MY ORDER FOR: Oncology Market Opportunities, Strategies, and Forecasts ALL REPORTS ARE AVAILABLE IN EITHER PRINT OR PDF- PDF PRINT ENCLOSED IS MY CHECK FOR $2,800 FOR SINGLE COPY, $3,800 FOR WEB SITE POSTING PLEASE BILL MY COMPANY USING P.O. NUMBER PLEASE CHARGE MY MASTERCARD/VISA/AMERICAN EXPRESS CARD NUMBER EXP. DATE If charging to a Credit card you may the order form, but not the card information Fax or Call with credit card information - Do not send card number as - You may send the order as ADDITIONAL $375 (EXTRA COPY PRICE IN EFFECT ONLY WITH INITIAL ORDER) NAME TITLE SIGNATURE COMPANY DIVISION ADDRESS CITY STATE / ZIP TELEPHONE FAX PLEASE NOTE: RESIDENTS OF MASSACHUSETTS AND CONNECTICUT MUST INCLUDE APPROPRIATE SALES TAX SUBSCRIBERS OUTSIDE THE UNITED STATES MUST PROVIDE PREPAYMENT IN U.S. FUNDS
Breath Analyzer Market Opportunities, Market Forecasts, and Market Strategies,
Breath Analyzer Market Opportunities, Market Forecasts, and Market Strategies, 2005-2011 Breath Analyzer Market Assessment Picture of fish breath by Susan Eustis WinterGreen Research, Inc. Lexington, Massachusetts
More informationOncology Pipeline Analytics
Oncology Pipeline Analytics Trials, Drug Classes, Indications, Correlations and Strategies Report Brochure O n c o l o g y P i p e l i n e A n a l y t i c s Greystone Research Associates is pleased to
More informationOncology Market Forecast To 2013
Oncology Market Forecast To 2013 How do you uncover the threats and opportunities that your oncology drug will face this year, next year and each year after that? Our new report answers your questions
More informationOrthopedic Surgical Robots and Surgical Robotic Assist Robots Market Shares, Strategies, and Forecasts, Worldwide, 2016 to 2022
Orthopedic Surgical Robots and Surgical Robotic Assist Robots Market Shares, Strategies, and Forecasts, Worldwide, 2016 to 2022 Mountains of Opportunity Picture by Susan Eustis WinterGreen Research, Inc.
More informationOxygen Concentrator Market Opportunities, Strategies, and Forecasts, 2006 to Oxygen Concentrator. Picture by Susie Eustis
Oxygen Concentrator Market Opportunities, Strategies, and Forecasts, 2006 to 2012 Oxygen Concentrator Picture by Susie Eustis MOUNTAINS OF OPPORTUNITY WinterGreen Research, Inc. Lexington, Massachusetts
More informationSickle-cell Anemia Therapeutics Market in the US
Sickle-cell Anemia Therapeutics Market in the US 2015-2019 Sickle-cell Anemia Therapeutics Market in the US 2015-2019 Sector Publishing Intelligence Limited (SPi) has been marketing business and market
More informationOncology Therapeutics Market in India to 2018
Oncology Therapeutics Market in India to 2018 Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players GBI Research Report Guidance GBI Research
More informationNoninvasive Glucose Monitors to 2022
Noninvasive Glucose Monitors to 2022 Devices, Technologies, Players and Prospects Report Prospectus Greystone Research associates N o n i n v a s i v e G l u c o s e M o n i t o r s t o 2 0 2 2 Greystone
More informationRadiology Oncology Surgical Robots Market Shares, Strategies, and Forecasts, Worldwide, 2016 to 2022
Radiology Oncology Surgical Robots Market Shares, Strategies, and Forecasts, Worldwide, 2016 to 2022 Mountains of Opportunity Picture by Susan Eustis WinterGreen Research, Inc. Lexington, Massachusetts
More informationRussia Cardiac Assist Devices Market Outlook to 2021
Russia Cardiac Assist Devices Market Outlook to 2021 Russia Cardiac Assist Devices Market Outlook to 2021 BioPortfolio has been marketing business and market research reports from selected publishers for
More informationGlobal Skin Cancer Diagnosis and Therapeutics Market Research and Forecast
Report Information More information from: https://www.wiseguyreports.com/reports/3186925-global-skin-cancer-diagnosis-and-therapeuticsmarket-research Global Skin Cancer Diagnosis and Therapeutics Market
More informationNoninvasive Glucose Monitors Devices, Technologies, Players and Prospects
Report Prospectus Noninvasive Glucose Monitors Devices, Technologies, Players and Prospects 1 Improving Diabetes Management For diabetes patients, glucose monitoring is a way of life, a several-times-per-day
More informationVascular Endothelial Growth Factor Inhibitor Market
May 2017 Report Id : REP-GB-3292 Status : Ongoing Category : Healthcare, Pharmaceuticals & Medical Devices 2015 Future Market Insights, All Rights Reserved About Future Market Insights Future Market Insights
More informationBRIC DIABETES DRUGS MARKET
BRIC DIABETES DRUGS MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d M a
More informationCOPD and Asthma Devices Market by Inhalers Type (Drug powder, Metered Dose, Soft Mist), Nebulizers (Compressor, Ultrasonic, Mesh) - Global
COPD and Asthma Devices Market by Inhalers Type (Drug powder, Metered Dose, Soft Mist), Nebulizers (Compressor, Ultrasonic, Mesh) - Global Opportunity Analysis and Industry Forecasts, 2015-2022 COPD and
More informationGASTRIC CANCER TESTING, TREATMENT AND PREVENTION: TECHNOLOGIES AND GLOBAL MARKETS. HLC174A October Usha Nagavarapu Project Analyst
GASTRIC CANCER TESTING, TREATMENT AND PREVENTION: TECHNOLOGIES AND GLOBAL MARKETS HLC174A October 2015 Usha Nagavarapu Project Analyst ISBN: 1-62296-167-6 BCC Research 49 Walnut Park, Building 2 Wellesley,
More informationREFERENCE CODE GDHC476DFR PUBLICAT ION DATE NOVEMBER 2014 CYRAMZA (COLORECTAL CANCER) FORECAST AND MARKET ANALYSIS TO 2023
REFERENCE CODE GDHC476DFR PUBLICAT ION DATE NOVEMBER 2014 CYRAMZA (COLORECTAL CANCER) Executive Summary Table below presents the key metrics of Cyramza for colorectal cancer (CRC) in the eight major pharmaceutical
More informationIndustry Company Products Pipeline Risks/Catalysts Valuation Q&A. Agenda
Industry Company Products Pipeline Risks/Catalysts Valuation Q&A Agenda 1 Pharmaceutical/Biotech Pharmaceutical companies Simple molecules made by chemical process taken orally Biotech companies Complicated
More informationHALOZYME REPORTS SECOND QUARTER 2018 RESULTS
Contacts: Robert H. Uhl Managing Director Westwicke Partners, LLC 858-356-5932 robert.uhl@westwicke.com Laurie Stelzer 858-704-8222 ir@halozyme.com FOR IMMEDIATE RELEASE HALOZYME REPORTS SECOND QUARTER
More informationREFERENCE CODE GDHC472DFR PUBLICAT ION DATE NOVEM BER 2014 STIVARGA (COLORECTAL CANCER) FORECAST AND MARKET ANALYSIS TO 2023
REFERENCE CODE GDHC472DFR PUBLICAT ION DATE NOVEM BER 2014 STIVARGA (COLORECTAL CANCER) Executive Summary Table below presents the key metrics for Stivarga for colorectal cancer (CRC) in the eight major
More informationBariatric Surgery Devices - North America Analysis and Market Forecasts
Bariatric Surgery Devices - North America Analysis and Market Forecasts Bariatric Surgery Devices - North America Analysis and Market Forecasts BioPortfolio has been marketing business and market research
More informationUS pharmaceutical market: trends, issues, forecast. Doug Long Vice President Industry Relations IMS Health
US pharmaceutical market: trends, issues, forecast Doug Long Vice President Industry Relations IMS Health 2006 Strategic management review The World Pharmaceutical Market All reproduction rights, quotations,
More informationBRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook to 2020
BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook Reference Code: GDMECR0130PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables...
More informationREFERENCE CODE GDHC471DFR PUBLICAT ION DATE NOVEM BER 2014 VECTIBIX (COLORECTAL CANCER) FORECAST AND MARKET ANALYSIS TO 2023
REFERENCE CODE GDHC471DFR PUBLICAT ION DATE NOVEM BER 2014 VECTIBIX (COLORECTAL CANCER) Executive Summary Table below presents the key metrics for Vectibix for colorectal cancer (CRC) in the eight major
More informationAsia-Pacific Bariatric Surgery Devices Market Outlook to 2020
Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020 Reference Code: GDMECR0195DB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List
More informationInfinity Highlights Promising Preclinical Hedgehog Data and Announces First Quarter Financial Results
Infinity Highlights Promising Preclinical Hedgehog Data and Announces First Quarter Financial Results Heat Shock Protein 90 Program Continues to Advance Toward Potential Registration Trial CAMBRIDGE, Mass.,
More informationOncology Financial Navigation
Oncology Financial Navigation Stephanie Boecher MSN - Director of Oncology & Neuroscience Services Rachel Faustner BBA Oncology Financial Navigator Advocate Sherman Hospital Cancer Center Financial Toxicity
More informationNEWS RELEASE Media Contact: Megan Pace Investor Contact: Kathee Littrell Patient Inquiries: Ajanta Horan
NEWS RELEASE Media Contact: Megan Pace 650-467-7334 Investor Contact: Kathee Littrell 650-225-1034 Patient Inquiries: Ajanta Horan 650-467-1741 GENENTECH RECEIVES COMPLETE RESPONSE LETTER FROM FDA FOR
More informationChina Insulin Industry Report, Jan. 2011
China Insulin Industry Report, 2010 Jan. 2011 This report analyzes the status, competition pattern and development direction of the insulin industry Focuses on the operation and development prospect of
More informationBrochure More information from
Brochure More information from http://www.researchandmarkets.com/reports/2375238/ Breast Imaging Technologies Market (Digital Mammography,3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular
More informationHIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse
HIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs),
More informationTHE COST DRIVERS OF CANCER CARE
THE COST DRIVERS OF CANCER CARE Debra Patt, MD, MPH, MBA David Eagle, MD Ted Okon, MBA Don Sharpe 20156Community Oncology Alliance 1 Welcome & Introductions Debra Patt, MD, MPH, MBA Director of Public
More informationOrally Inhaled Corticosteroids to 2022
Greystone Research Associates 1+603-595-4340 April 2015 Orally Inhaled Corticosteroids to 2022 Drugs, Devices, Markets and Forecasts Contents A Comprehensive Market Analysis Report Scope & Overview 2 Table
More informationChina Oral Hypoglyceimic Agents (OHAs) Industry Report, Feb. 2011
China Oral Hypoglyceimic Agents (OHAs) Industry Report, 2010 Feb. 2011 This report Analyzes the status quo and prospect of Chinese OHAS Market. Related Products China Interventional Cardiovascular Device
More informationCancer Immunotherapy Artificial Intelligence: Market Shares, Strategies, and Forecasts, 2017 to 2023
Cancer Immunotherapy Artificial Intelligence: Market Shares, Strategies, and Forecasts, 2017 to 2023 Table of Contents Cancer Immunotherapy Artificial Intelligence: Executive Summary The study is designed
More informationNEWS RELEASE Media Contact: Krysta Pellegrino (650) Investor Contact: Sue Morris (650) Advocacy Contact: Kristin Reed (650)
NEWS RELEASE Media Contact: Krysta Pellegrino (650) 225-8226 Investor Contact: Sue Morris (650) 225-6523 Advocacy Contact: Kristin Reed (650) 467-9831 FDA APPROVES AVASTIN IN COMBINATION WITH CHEMOTHERAPY
More information37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE
37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE January 2019 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
More informationEU5 Bariatric Surgery Procedures Outlook to 2020
EU5 Bariatric Surgery Procedures Outlook to 2020 Reference Code: GDMECR0089PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of Figures...
More informationAsia-Pacific Electrophysiology Market Outlook to 2020
Asia-Pacific Electrophysiology Market Outlook to 2020 Reference Code: GDMECR0114DB Publication Date: May 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 5 1.2 List of Figures...
More informationAsia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020
Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Reference Code: GDMECR0107PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3
More informationRecent Surge in FDA Approvals Shakes up the Oncology Promotional Landscape. Perjeta. Stivarga. Marquibo. Bosulif. Xtandi. Krypolis.
Krypolis Bosulif Inlyta Erivedge Xtandi Stivarga Alimta Gleevec Marquibo Perjeta Synribo Zaltrap Recent Surge in FDA Approvals Shakes up the Oncology Promotional Landscape By Bill Bowman, JD What a year
More informationNorth America Cardiac Rhythm Management (CRM) Procedures Outlook to 2021
North America Cardiac Rhythm Management (CRM) Procedures Outlook to 2021 North America Cardiac Rhythm Management (CRM) Procedures Outlook to 2021 BioPortfolio has been marketing business and market research
More informationCHAPTER ONE: EXECUTIVE SUMMARY
CHAPTER ONE: EXECUTIVE SUMMARY Introduction Scope and Methodology Total Size and Growth of the Market Issues and Trends Affecting Market Leading Competitors CHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDS
More informationMexico Ostomy Drainage Bags Market Outlook to 2020
Mexico Ostomy Drainage Bags Market Outlook to 2020 Reference Code: GDMECC0990DB Publication Date: October 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List of Figures...
More informationFor personal use only
Cancer killing viruses Oncolytic Virotherapeutics Bryan Dulhunty Managing Director Bell Potter Life Sciences Conference Building a Global Profile May 2102 bryan.dulhunty@viralytics.com www.viralytics.com
More informationCancer Researchers Report Longer Survival Rates With Immunotherapy
http://nyti.ms/1jlz74z HEALTH NYT NOW Cancer Researchers Report Longer Survival Rates With Immunotherapy By ANDREW POLLACK JUNE 2, 2014 CHICAGO Drugs that unleash the body s immune system to combat tumors
More informationChina Cranio Maxillofacial Fixation (CMF) Market Outlook to 2020
China Cranio Maxillofacial Fixation (CMF) Market Outlook to 2020 Reference Code: GDMECC0079DB Publication Date: March 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2
More informationREFERENCE CODE GDHC207DFR PUBLICAT ION DATE JUNE 2013 GILOTRIF (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC207DFR PUBLICAT ION DATE JUNE 2013 GILOTRIF (NON-SMALL CELL LUNG CANCER) GILOTRIF (NON-SMALL CELL LUNG CANCER) - Executive Summary Gilotrif: Key Metrics in NSCLC Markets 2022 Gilotrif
More informationStructural Heart Devices Market by Product (Structural Heart Repair Devices and Replacement Valves), Age Group (Pediatric and Adult), and Indication
Structural Heart Devices Market by Product (Structural Heart Repair Devices and Replacement Valves), Age Group (Pediatric and Adult), and Indication (Atrial Septal Defect (ASD), Patent Foramen Ovale (PFO),
More informationFY2007 Consolidated Financial Overview
FY2007 Consolidated Financial Overview CHUGAI PHARMACEUTICAL CO., LTD. Executive Vice President and CFO Ryuzo Kodama January 30/31, 2008 Forward-Looking Statements This presentation may include forward-looking
More informationWorldwide Nanotechnology Dental Implant Market Shares, Strategies, and Forecasts, 2009 to Dental Implants Serve the Aging Population Worldwide
Worldwide Nanotechnology Dental Implant Market Shares, Strategies, and Forecasts, 2009 to 2015 Dental Implants Serve the Aging Population Worldwide Picture by Susie Eustis MOUNTAINS OF OPPORTUNITY WinterGreen
More informationExecutive Summary. Reproduction prohibited v
Kinases are a large family of proteins that have now become firmly established as a major class of drug targets for the pharmaceutical industry. The sequencing of the Human Genome has led to the identification
More informationExoskeletons: Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021
Exoskeletons: Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021 Mountains of Opportunity Picture by Susan Eustis Lexington, Massachusetts CHECK OUT THESE KEY TOPICS Exoskeletons: Wearable
More informationU.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon),
U.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon), Orexin Antagonist) & OTC Treatment (Antihistamine, Melatonin,
More informationUrinary Incontinence Products Market in Europe
Urinary Incontinence Products Market in Europe 2015-2019 Urinary Incontinence Products Market in Europe 2015-2019 BioPortfolio has been marketing business and market research reports from selected publishers
More informationPrevention and Treatment of Prostate Cancer: Technologies and Global Markets March Usha Nagavarapu. Report # PHM113B
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets March 2017 Usha Nagavarapu Report # PHM113B Table of Contents Chapter 1 Introduction... 1 Introduction... 1 Study goals and
More informationCHECK OUT THESE KEY TOPICS
Breath Analyzer Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 Breathalyzer: Crackdown on Drinking and Driving Worldwide, even on Bicycles, Crackdown on Alcohol at Work, New Healthcare
More informationREFERENCE CODE GDHC198DFR PUBLICAT ION DATE JUNE 2013 TARCEVA (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC198DFR PUBLICAT ION DATE JUNE 2013 TARCEVA (NON-SMALL CELL LUNG CANCER) Executive Summary Tarceva (erlotinib): Key Metrics in NSCLC Markets 2012 Tarceva Sales US 5EU Japan China India
More informationREFERENCE CODE GDHC200DFR PUBLICAT ION DATE JUNE 2013 AVASTIN (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC200DFR PUBLICAT ION DATE JUNE 2013 AVASTIN (NON-SMALL CELL LUNG CANCER) AVASTIN (NON-SMALL CELL LUNG CANCER) - Executive Summary Avastin (bevacizumab): Key Metrics in NSCLC Markets 2012
More informationH. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review
H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review BioPortfolio has been marketing business and market research reports
More informationREFERENCE CODE GDHC199DFR PUBLICAT ION DATE JUNE 2013 XALKORI (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC199DFR PUBLICAT ION DATE JUNE 2013 XALKORI (NON-SMALL CELL LUNG CANCER) Executive Summary Xalkori (crizotinib): Key Metrics in NSCLC Markets 2012 Xalkori Sales US 5EU Japan China India
More informationProton Therapy Market Outlook - Global Analysis
Proton Therapy Market Outlook - Global Analysis Proton Therapy Market Outlook - Global Analysis BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen
More informationGastric Cancer. Introduction
Gastric Cancer Introduction Despite advances in surgery and the use of multimodality therapy, survival outcomes remain poor for gastric cancer patients. There is an urgent need for more effective therapies
More informationPoland Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022
Poland Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022 Poland Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton
More informationNew Prognostic Markers in Acute Myeloid Leukemia (AML)
New Prognostic Markers in Acute Myeloid Leukemia (AML) For more visit ResearchToPractice.com/5MJCMDSAML CME INFORMATION OVERVIEW OF ACTIVITY Acute myeloid leukemia (AML) and the myelodysplastic syndromes
More informationPascal Soriot, Head of Strategic Marketing
Workshop Marketing a cancer drug Pascal Soriot, Head of Strategic Marketing Trends in the oncology market Europe/ RoW compared to US Marketing cancer drugs successfully Leveraging 1 st mover advantage
More informationGlobal Hearing Aids Market (by Devices, Implant Types, OTC Amplifiers, Diagnostic Instruments), Sales Volume, Company Analysis and Forecast to 2022
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Hearing Aids Market (by Devices, Implant Types, OTC Amplifiers, Diagnostic Instruments), Sales Volume, Company
More informationAstraZeneca to Acquire Bristol- Myers Squibb Share of Global Diabetes Alliance. Becoming Global Leaders In Diabetes
AstraZeneca to Acquire Bristol- Myers Squibb Share of Global Diabetes Alliance Becoming Global Leaders In Diabetes 19th December 2013 Cautionary Statement Regarding Forward-Looking Statements In order,
More informationAlpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic
Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others (Cirrhosis, and Hepatitis)) & Geography-Forecast
More informationRESIDENT FALLS A Guide to Prevention, Assessment, and Response
Long-Term Care Risk Management: RESIDENT FALLS A Guide to Prevention, Assessment, and Response Carole Eldridge, MSN, RN, CNAA, BC Contents About the Author........................................ v Chapter
More informationHip and Knee Orthopedic Surgical Robots: Market Shares, Strategies, and Forecasts, Worldwide,
Hip and Knee Orthopedic Surgical Robots: Market Shares, Strategies, and Forecasts, Worldwide, 2016-2022 Table of Contents Hip and Knee Orthopedic Surgical Robots: Executive Summary The study is designed
More informationThe Cigarette Market in Greece
The Cigarette Market in Greece Product Code: CG0145MR Published Date: April 2015 Report Price: US$ 975 (Single Copy) Synopsis Cigarettes in Greece report is a qualitative report providing extensive and
More informationSAMPLE. Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to Reference Code: GDME0166BDB
Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Reference Code: GDME0166BDB Publication Date: January 2013 GlobalData. This report is a licensed product
More informationDecision Making Across the Lifespan
40th Annual Meeting EXHIBIT AND SPONSORSHIP October 14-17, 2018 Fairmont The Queen Elizabeth Montreal, QC, Canada Decision Making Across the Lifespan 2018 OCTOBER 14th - 17th SMDM 390 Amwell Road, Suite
More informationBlood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, Single User License: US $ 4595
Transparency Market Research Blood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019 Single User License: US $ 4595 Buy Now Request Sample
More informationSAMPLE. Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Reference Code: GDME0165BDB Publication Date: January 2013 GlobalData. This report
More informationINTERIM MANAGEMENT STATEMENT Q3 2017
INTERIM MANAGEMENT STATEMENT Q3 2017 Significant progress across all clinical programs New pre-clinical immunooncology data to be presented during R&D Day in New York Research & Development highlights:
More informationToGA: Trastuzumab with Standard Chemotherapy for HER2-Positive Advanced Gastric Cancer (GC)
ToGA: Trastuzumab with Standard Chemotherapy for HER2-Positive Advanced Gastric Cancer (GC) For more visit ResearchToPractice.com/5MJC CME INFORMATION OVERVIEW OF ACTIVITY Each year, thousands of clinicians
More informationNon Alcoholic Fatty Liver Disease (NAFLD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018
Non Alcoholic Fatty Liver Disease (NAFLD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 Non Alcoholic Fatty Liver Disease (NAFLD) - Global API Manufacturers, Marketed and Phase
More informationMyriad Genetics Corporate Presentation 6/4/13
Myriad Genetics Corporate Presentation 6/4/13 Forward Looking Statement Some of the information presented here today may contain projections or other forward-looking statements regarding future events
More informationGlobal Insulin Pumps Market
Global Insulin Pumps Market 2016-2020 Global Insulin Pumps Market 2016-2020 BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio
More informationMexico Milling Machine for Dental Clinics Industry 2016 Market Research Report
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Mexico Milling Machine for Dental Clinics Industry Market Research Report Mexico Milling Machine for Dental Clinics
More informationWorldwide Nanotechnology Dental Implants-- Markets Reach $8.1 By 2015
Worldwide Nanotechnology Dental Implants-- Markets Reach $8.1 By 2015 LEXINGTON, Massachusetts (March 14, 2009) WinterGreen Research announces that it has a new study on Worldwide nanotechnology dental
More informationThe Cigarette Market in Belarus
The Cigarette Market in Belarus Product Code: CG0155MR Published Date: June 2015 Report Price: US$ 975 (Single Copy) Synopsis Cigarettes in Belarus report is a qualitative report providing extensive and
More informationHER2-Negative Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023
HER2-Negative Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023 HER2-Negative Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023 BioPortfolio has been marketing business and market
More informationMarch 11, Walter E. Washington Convention Center
March 11, 2017 Walter E. Washington E X E C U T I V E S U M M A RY WHO: The Leukemia & Lymphoma Society (LLS) is the world s largest private organization concerned solely with funding research toward cures
More informationREFERENCE CODE GDHC1032FPR PUBLICAT ION DATE M ARCH 2014 PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES - CURRENT AND FUTURE PLAYERS
REFERENCE CODE GDHC1032FPR PUBLICAT ION DATE M ARCH 2014 PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES - Executive Summary Human PapillomaVirus (HPV) Vaccine Sales Expected to Grow Modestly During the Forecast
More informationGlobal HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country ( )
Global HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country (2017-2022) By Region- North America, Europe, APAC and RoW By Country - United
More informationAntifungal Drugs Market by Drug Type [Echinocandins {Caspofungin, Micafungin, Anidulafungin and Others}, Azoles {Imidazoles, Voricanazole, Thiazoles
Antifungal Drugs Market by Drug Type [Echinocandins {Caspofungin, Micafungin, Anidulafungin and Others}, Azoles {Imidazoles, Voricanazole, Thiazoles and Others}, Polyenes {Amphotericin B, Candicidin, Hamycin,
More informationPresentation to AGM 9 November Deborah Rathjen CEO & Managing Director
Presentation to AGM 9 November 2011 Deborah Rathjen CEO & Managing Director Safe Harbor Statement Factors Affecting Future Performance This presentation contains "forward looking" statements within the
More informationREFERENCE CODE GDHC196DFR PUBLICAT ION DATE JUNE 2013 ABRAXANE (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC196DFR PUBLICAT ION DATE JUNE 2013 ABRAXANE (NON-SMALL CELL LUNG CANCER) Executive Summary Abraxane (nab-paclitaxel): Key Metrics in NSCLC Markets 2012 Abraxane Sales US 5EU $98.34m
More informationChina Animal Vaccine Industry Report, Jun 2012
China Animal Vaccine Industry Report, 2011-2012 Jun 2012 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis, insight
More informationVaccine Technologies and Global Markets
A BCC Research Pharmaceutical Report and Global Markets PHM014D Use this report to: Learn about the strengths and weaknesses of each category of human and veterinary vaccine to prevent or treat infectious
More informationInfertility Treatment Devices Market by Product (Cryosystem, Imaging System, Incubator, Micromanipulator, Ovum Aspiration Pump, Sperm Analyzer,
Infertility Treatment Devices Market by Product (Cryosystem, Imaging System, Incubator, Micromanipulator, Ovum Aspiration Pump, Sperm Analyzer, Workstation), Technology (AI, Gamete Donation, IVF, ICSI,
More informationREFERENCE CODE GDHC386DFR PUBLICAT ION DATE M ARCH 2014 GARDASIL (PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC386DFR PUBLICAT ION DATE M ARCH 2014 GARDASIL (PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022 Executive Summary Gardasil: Key Metrics in Nine Major
More informationChina Human Vaccine Industry Report, May 2012
China Human Vaccine Industry Report, 2011-2012 May 2012 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis, insight and
More informationUnited States Tuberculosis Vaccine Industry 2016 Market Research Report
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > United States Tuberculosis Vaccine Industry 2016 Market Research Report United States Tuberculosis Vaccine Industry
More informationMedifocus, Inc. OTCQX: MDFZF TSXV: MFS
Medifocus, Inc. OTCQX: MDFZF TSXV: MFS www.medifocusinc.com Develops and commercializes minimally invasive focused heat thermotherapy systems for the treatment of cancer and other diseases January 2014
More informationDIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC)
DIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC) R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p
More informationInterChina Insight. Partnering up to fight cancer. Strategies for the China oncology market. InterChina Consulting. By Rick Woo April 03, 2013
Strategies for the China oncology market By Rick Woo InterChina Consulting 英特华投资咨询有限公司 Beijing Shanghai Madrid Washington DC Strategy M&A Advisory IMAP China 2013 InterChina Consulting All Rights Reserved
More information